Part I, cerium (iv) ammonium nitrate catalyzed ring-opening of butadiene monoxide : Part II, biphenyl and metal ion photoinduced single electron transfer ring-opening of butadiene monoxide Part III, attempted photosensitized rearrangement of butadiene monoxide, boron trifluoride etherate catalyzed fluorination of cyclohexene oxide

N

In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models

The objective of this work was to characterize the in vitro (Plasmodium falciparum) and in vivo (Plasmodium berghei) activity profile of the recently discovered lead compound SSJ-183. The molecule showed in vitro a fast and strong inhibitory effect on growth of all P. falciparum blood stages, with a tendency to a more pronounced stage-specific action on ring forms at low concentrations. Furthermore, the compound appeared to be equally efficacious on drug-resistant and drug-sensitive parasite strains. In vivo, SSJ-183 showed a rapid onset of action, comparable to that seen for the antimalarial drug artesunate. SSJ-183 exhibited a half-life of about 10 hours and no significant differences in absorption or exposure between noninfected and infected mice. SSJ-183 appears to be a promising new lead compound with an attractive antimalarial profile